QuantalX Neuroscience LTD, with its slogan "Brain Health Made Accessible," aims to revolutionize the field of brain health diagnostics. Established in 2014, the company specializes in objective brain health diagnosis, offering a first-in-class device named Delphi-MD. This innovative technology provides functional visualization and quantitative analysis, enabling early detection and differential diagnosis of brain disorders. With a focus on biotechnology, healthcare, and medical devices, QuantalX Neuroscience LTD is poised to make significant contributions to the advancement of brain health diagnosis and treatment.
General Information
Get notified when QuantalX Neuroscience LTD moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track QuantalX Neuroscience LTD
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About QuantalX Neuroscience LTD
Taxonomy: Neuroscience, Alzheimer's, Clinical Diagnosis, Medical Device, Start-up, CE, FDA, Preventative Care, Brain Health, Non-Invasive, Point of Care, Brain Function Test
No funding data available for QuantalX Neuroscience LTD yet.
Get notified when QuantalX Neuroscience LTD raises fundingQuantalX Neuroscience LTD Alternatives & Competitors
Empowering care with validated AI-driven tools for early detection and better management of neurolog...
The Swoop® system brings MR brain imaging within reach. Nasdaq: $HYPR
FAQ About QuantalX Neuroscience LTD
Don't just browse. Track.
Signal Tracker monitors QuantalX Neuroscience LTD and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.